So, CF33 works with CD19 pre-clinical and we already know that that will translate into the human trials as well. Now remember, CD19 so far is the only CD to have been approved world wide but others 17,20,21,22 are in progress. Huge combo opportunities are awaiting IMU.
GLTA
Ann: onCARlytics to be showcased in three abstracts at SITC, page-10
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
0.002(3.57%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.9¢ | 5.6¢ | $447.3K | 7.706M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 377945 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 1172600 | 19 |
View Market Depth
| Last trade - 12.15pm 23/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |